Renaissance Technologies's PRCT Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 117,466 shares of PROCEPT BioRobotics Corporation (PRCT) worth $3.7 M, representing 0.01% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in PRCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 278,466 shares. Largest reduction occurred in Q2 2025, reducing 314,466 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's PROCEPT BioRobotics Corporation (PRCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly PROCEPT BioRobotics Corporation (PRCT) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +117,466 | New Buy | 117,466 | $31.46 |
| Q2 2025 | -314,466 | Sold Out | 0 | $0.00 |
| Q1 2025 | +36,000 | Add 12.93% | 314,466 | $58.26 |
| Q4 2024 | +278,466 | New Buy | 278,466 | $80.52 |
| Q3 2024 | -45,966 | Sold Out | 0 | $0.00 |
| Q2 2024 | +45,966 | New Buy | 45,966 | $61.09 |
| Q2 2023 | -63,566 | Sold Out | 0 | $0.00 |
| Q1 2023 | +63,566 | New Buy | 63,566 | $0.03 |
| Q1 2022 | -179,300 | Sold Out | 0 | $0.00 |
| Q4 2021 | +179,300 | New Buy | 179,300 | $25.01 |
Renaissance Technologies's PROCEPT BioRobotics Corporation Investment FAQs
Renaissance Technologies first purchased PROCEPT BioRobotics Corporation (PRCT) in Q4 2021, acquiring 179,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held PROCEPT BioRobotics Corporation (PRCT) for 10 quarters since Q4 2021.
Renaissance Technologies's largest addition to PROCEPT BioRobotics Corporation (PRCT) was in Q4 2024, adding 278,466 shares worth $22.42 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 117,466 shares of PROCEPT BioRobotics Corporation (PRCT), valued at approximately $3.7 M.
As of the Q4 2025 filing, PROCEPT BioRobotics Corporation (PRCT) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in PROCEPT BioRobotics Corporation (PRCT) was 314,466 shares, as reported at the end of Q1 2025.